echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Feed Industry News > Feng Hao's Talk: The Future Development Of veterinary Medicine Industry

    Feng Hao's Talk: The Future Development Of veterinary Medicine Industry

    • Last Update: 2020-06-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    to talk about the future development of China's veterinary drug industry, or first analyze the current backgroundIn terms of market share, biologics account for 40% in China's veterinary drug sector, 15% biosecurity products, 15% of functional health care products and 30% of chemical therapy drugsIn terms of ingredient efficacy, China's veterinary products have Chinese herbal medicine, chemical drugs, micro-ecological preparations, biological productsjF7
    The current situation facing China's veterinary drug industry: (1) the global improvement of public health awareness;jF7
    (2) Global food safety standards;jF7
    (3) Environmental protection and sustainable development of animal husbandry;jF7
    (4) Restrictions on the use of antibiotics as additives;jF7
      (5) The research and development of Chinese herbal medicine will be highly valued; jF7
      (6) Biological products may become Noah's Ark jF7
      I think this status quo will bring certain challenges and opportunities to the industry: 1, the national regulatory measures will be unprecedentedly strict, forced to stop most of the illegal enterprises; Opportunity; 4, speculation is no longer, practitioners want to retreat, career transformation, leave the veterinary drug industry; 5, market norms, consumer rational judgment, demand transformation, sales difficulty; 6, group norms, product portfolio application, evaluation transformation, service standards jF7
      The resulting dilemma in the marketing of veterinary drug enterprises will also increase: jF7 1, the control of the terminal is weak; jF7
      2, the end of the era of high profit seofp price sending terminal prices; jF7
      3, rebate, promotion, tourism pale helpless; jF7
      4, flat, large-scale, professional development needs jF7
      Through the above analysis, I think that in the new situation, veterinary drug enterprise marketing opportunities are mainly reflected in the following aspects: jF7 1, side-by-side - to choose the real responsibility, research and development, good strategy, understand the brand of standardized legal enterprises, and cooperate with it jF7
      2, do subtraction - vigorously reduce products, precision advantages of products, optimize product portfolio promotion programs, the use of "subtraction" means of operation, focus on quality, the enterprise's research and development, positioning, publicity is concentrated in several products jF7
      3, create a brand - to create a national large single product is very difficult, so you can first create a regional "big single" consumer brand, continue to guide the "competition" consumer trend Moreover, the large and regional products can help enterprises save resources and costs jF7
      4, practice internal skills - to strengthen their own business comprehensive skills training, from specialization to professional sales jF7
      5, the big layout - the current situation to create heroes, heroes to create the situation, strong and strong joint, in order to create a great cause For example, I have resources, talent, platform advantages, but lack of network resources, and he has network advantages, then we can strong unity and common development jF7
      Review the situation, timely seize the existing market opportunities, insight first, can do a region 80 million, never the province to do a billion! Can a province do 2 to, never do 3 billion nationally! China's veterinary drug industry is currently in a period of rapid change, will certainly eliminate a batch, make a large batch, in the end will become which echelon, depending on your opportunity to control! jF7
      Feng Hao, a graduate of Northwest Agricultural and Forestry University of Science and Technology, senior veterinary surgeon, mainly engaged in pig farm production management and disease prevention, is currently the Beijing Zhongnon Yingtai Biotechnology Co., Ltd technical director In China's animal health, contemporary animal husbandry, veterinary medicine market guide published more than ten papers jF7 to talk about the future development of China's veterinary drug industry, or first analyze the current background In terms of market share, biologics account for 40% in China's veterinary drug sector, 15% biosecurity products, 15% of functional health care products and 30% of chemical therapy drugs In terms of ingredient efficacy, China's veterinary products have Chinese herbal medicine, chemical drugs, micro-ecological preparations, biological products jF7
      The current situation facing China's veterinary drug industry: (1) the global improvement of public health awareness; jF7
      (2) Global food safety standards; jF7
      (3) Environmental protection and sustainable development of animal husbandry; jF7
      (4) Restrictions on the use of antibiotics as additives; jF7
      (5) The research and development of Chinese herbal medicine will be highly valued; jF7
      (6) Biological products may become Noah's Ark jF7
      I think this status quo will bring certain challenges and opportunities to the industry: 1, the national regulatory measures will be unprecedentedly strict, forced to stop most of the illegal enterprises; Opportunity; 4, speculation is no longer, practitioners want to retreat, career transformation, leave the veterinary drug industry; 5, market norms, consumer rational judgment, demand transformation, sales difficulty; 6, group norms, product portfolio application, evaluation transformation, service standards jF7
      The resulting dilemma in the marketing of veterinary drug enterprises will also increase: jF7 1, the control of the terminal is weak; jF7
      2, the end of the era of high profit seofp price sending terminal prices; jF7
      3, rebate, promotion, tourism pale helpless; jF7
      4, flat, large-scale, professional development needs jF7
      Through the above analysis, I think that in the new situation, veterinary drug enterprise marketing opportunities are mainly reflected in the following aspects: jF7 1, side-by-side - to choose the real responsibility, research and development, good strategy, understand the brand of standardized legal enterprises, and cooperate with it jF7
      2, do subtraction - vigorously reduce products, precision advantages of products, optimize product portfolio promotion programs, the use of "subtraction" means of operation, focus on quality, the enterprise's research and development, positioning, publicity is concentrated in several products jF7
      3, create a brand - to create a national large single product is very difficult, so you can first create a regional "big single" consumer brand, continue to guide the "competition" consumer trend Moreover, the large and regional products can help enterprises save resources and costs jF7
      4, practice internal skills - to strengthen their own business comprehensive skills training, from specialization to professional sales jF7
      5, the big layout - the current situation to create heroes, heroes to create the situation, strong and strong joint, in order to create a great cause For example, I have resources, talent, platform advantages, but lack of network resources, and he has network advantages, then we can strong unity and common development jF7
      Review the situation, timely seize the existing market opportunities, insight first, can do a region 80 million, never the province to do a billion! Can a province do 2 to, never do 3 billion nationally! China's veterinary drug industry is currently in a period of rapid change, will certainly eliminate a batch, make a large batch, in the end will become which echelon, depending on your opportunity to control! jF7
      Feng Hao, a graduate of Northwest Agricultural and Forestry University of Science and Technology, senior veterinary surgeon, mainly engaged in pig farm production management and disease prevention, is currently the Beijing Zhongnon Yingtai Biotechnology Co., Ltd technical director In China's animal health, contemporary animal husbandry, veterinary medicine market guide published more than ten papers jF7
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.